Explore 3 Stock Ideas & Industry Insights Download Free Report

Solesence, Inc. Common Stock

Company price
0.856 USD 0.00(0%)
Last update at 2026-11-02T21:00:00Z
VOLUME
34538
Market Cap
57.94M

Momentum Score

…

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.85
Low
0.92
High
52 Week Price Range
0.61
Low
4.55
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.86
Dividend Yield
-
Revenue TTM
55.37M
Revenue Per Share
0.78
Gross Profit TTM
13.86M
Debt / Equity
1.38
ROE
-18.55%
Net Debt
23.03M
ROCE
7.73%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1.86M 4.46M -4.38M -2.64M 2.36M
Net income 1.79M 4.24M -4.39M -2.62M 2.32M
Selling general administrative 10.40M 7.22M 7.53M 7.58M 3.90M
Gross profit 16.03M 16.19M 7.83M 8.36M 8.69M
Reconciled depreciation 0.90M 0.93M 0.74M 0.57M 0.45M
Ebit 2.79M 5.13M -3.55M -2.26M 3.51M
Ebitda 3.69M 6.06M -2.80M -1.69M 3.96M
Depreciation and amortization 0.90M 0.93M 0.74M 0.57M 0.45M
Operating income 1.57M 5.13M -3.55M -2.26M 2.56M
Other operating expenses 60.49M 47.22M 40.84M 39.58M 26.92M
Interest expense 0.93M 0.67M 0.84M 0.38M 1.15M
Tax provision 0.07M 0.23M 0.01M -0.02M 0.04M
Net interest income -0.93M -0.67M -0.84M -0.38M -1.15M
Income tax expense 0.07M 0.23M 0.01M -0.02M 0.04M
Total revenue 62.06M 52.35M 37.30M 37.32M 29.48M
Total operating expenses 14.46M 11.06M 11.37M 10.62M 6.13M
Cost of revenue 46.04M 36.16M 29.47M 28.96M 20.79M
Total other income expense net 0.29M -0.67M -0.84M -0.38M -0.20M
Net income from continuing ops 1.79M 4.24M -4.39M -2.62M 2.32M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 50.05M 50.00M 32.88M 33.56M 28.39M
Other current assets 2.14M 2.80M 1.08M 0.87M 0.91M
Total liab 32.42M 35.06M 30.98M 27.91M 20.93M
Total stockholder equity 17.63M 14.95M 1.90M 5.65M 7.46M
Other current liab 2.59M 3.25M 0.74M 0.56M 0.50M
Common stock 0.71M 0.70M 0.50M 0.49M 0.49M
Capital stock 0.71M 0.70M 0.50M 0.49M 0.49M
Retained earnings -98.64M -100.43M -104.66M -100.07M -97.45M
Cash 1.29M 1.41M 1.72M 2.19M 0.66M
Total current liabilities 13.93M 25.77M 15.59M 13.84M 7.34M
Current deferred revenue 0.93M 5.57M 2.35M 2.23M 0.91M
Net debt 23.03M 13.89M 19.54M 15.92M 14.09M
Short term debt 6.02M 6.26M 6.11M 4.28M 2.04M
Short long term debt 4.77M 5.00M 4.81M 4.28M 1.35M
Short long term debt total 24.32M 15.30M 21.26M 18.11M 14.75M
Other stockholder equity 115.57M 114.67M 106.07M 105.23M 104.42M
Total current assets 28.78M 29.35M 16.30M 16.62M 11.60M
Net receivables 6.84M 4.87M 3.47M 4.73M 3.94M
Long term debt 10.50M - 6.00M 4.00M 1.00M
Inventory 18.51M 20.27M 10.03M 8.84M 6.09M
Accounts payable 4.39M 10.69M 6.39M 6.77M 3.89M
Non currrent assets other 14.37M 0.00M 0.00M 0.01M 0.01M
Non current assets total 21.28M 20.65M 16.58M 16.93M 16.80M
Capital lease obligations 9.05M 10.30M 10.45M 9.82M 12.40M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -4.56M -1.05M -2.82M -1.87M
Total cashflows from investing activities -2.14M -4.56M -1.05M -2.82M -1.87M
Net borrowings 10.27M -5.81M 2.52M 5.82M -0.98M
Total cash from financing activities 10.59M 2.27M 2.59M 6.00M -0.75M
Net income 1.79M 4.24M -4.39M -2.62M 2.32M
Change in cash -0.12M -0.31M -0.46M 1.53M -0.30M
Begin period cash flow 1.41M 1.72M 2.19M 0.66M 0.96M
End period cash flow 1.29M 1.41M 1.72M 2.19M 0.66M
Total cash from operating activities -8.57M 1.97M -2.01M -1.65M 2.32M
Issuance of capital stock 0.00M 6.00M 0.00M - -
Depreciation 0.90M 0.93M 0.74M 0.57M 0.45M
Other cashflows from investing activities -2.14M -4.56M - - -
Change to inventory 1.76M -10.24M -1.19M -2.74M -1.75M
Change to account receivables -1.97M -1.40M 1.06M -0.80M -1.00M
Other cashflows from financing activities 10.59M 8.08M 0.07M 6.11M 0.23M
Capital expenditures 2.14M 4.56M 1.05M 2.82M 1.87M
Change in working capital -11.83M -3.92M 0.87M -2.79M -0.56M
Stock based compensation 0.57M 0.72M 0.77M 0.62M 0.16M
Other non cash items -11.83M - - 2.57M -0.05M
Free cash flow -10.71M -2.59M -3.06M -4.47M 0.45M

Peer Comparison*

Sector: Consumer Defensive Industry: Household & Personal Products

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SLSN
Solesence, Inc. Common Stock
-
-%
0.86 - 11.36 1.05 4.35 1.42 27.69
PG
Procter & Gamble Company
-0.12
0.07%
163.56 23.58 22.62 4.07 7.24 4.40 16.08
LRLCF
L'Oréal S.A
4.50
0.94%
485.50 41.14 34.25 6.52 8.59 6.67 27.76
LRLCY
L’Oreal Co ADR
1.02
1.05%
98.04 32.44 25.64 5.16 6.03 4.79 19.51
UL
Unilever PLC ADR
1.18
1.81%
66.44 21.53 16.39 2.66 7.29 2.77 12.45

Profile*

Solesence, Inc. Common Stock

Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. It serves skin health, beauty, and wellness sectors. The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025. Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

1319 Marquette Drive, Romeoville, IL, United States, 60446

630 771 6708

115

Name Title Year Born
Mr. Kevin Cureton President, CEO & Director 1962
Ms. Laura Riffner Chief Financial Officer 1972

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…